Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Conserved escherichia coli immunogens

A technology of Escherichia coli and immunogenic polypeptides, applied in the field of immunity, can solve problems such as not pointing out conservation

Inactive Publication Date: 2012-09-12
NOVARTIS AG
View PDF72 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this list does not indicate what is conserved among the major parts of pathogenic E. coli, what are the conserved regions among such conserved proteins, or which of the thousands of potential proteins could be used in vaccines or Generating an adequate immune response to protect against pathogenic E. coli requires screening a large number of proteins to identify the best candidates

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Conserved escherichia coli immunogens
  • Conserved escherichia coli immunogens
  • Conserved escherichia coli immunogens

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0417] each as described in more detail herein, bacterial Ig-like domain (group 1) protein (orf405), influenza antigen 43 (orf1364), NodT-family outer membrane factor lipoprotein efflux transporter (orf1767), gspK (orf3515) , gspJ (orf3516), tonB-dependent siderophore receptor (orf3597), pilin (orf3613), upec-948, upec-1232, A-chain precursor of type 1 pilin (upec-1875), yap The H homologue (upec-2820), hemolysin A (recp-3768) and Sel1 repeat-containing protein (upec-5211) have been expressed and purified and confer protection against ExPEC strains in an animal model of sepsis.

[0418] Sequences of orthologs were obtained from various other E. coli strains.

[0419] Each protein-orf353 (SEQ ID NO:1-amino acid 21-162), bacterial Ig-like domain (group 1) protein (orf405) (SEQ ID NO:9-amino acid 595-1008), influenza antigen 43 (orf1364 ) (SEQ ID NO:27-amino acids 53-629), NodT-family outer membrane factor lipoprotein efflux transporter (orf1767) (SEQ ID NO:41-amino acids 15-457...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
adsorption capacityaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Homologs of the E. coli proteins orf353, bacterial lg-like domain (group 1) protein (orf405), flu antigen 43 (orfl 364), NodT-family outer-membrane-factor-lipoprotein efflux transporter (orfl 767), gspK (orf3515), gspJ (orf3516), toriB-dependent siderophore receptor (orO597), fibrial protein (orf3613), upec-948, upec- 1232. A chain precursor of the type- 1 fimbria! protein (upec- 1875), yapH homolog (upec-2820), hemolysin A (recp-3768), and Sel l repeat-containing protein (upec-521 1 ) from several pathogenic strains of E. coli have been identified with regions within the proteins that are conserved across all E. coli. Fragments corresponding to the conserved regions, especially immunogenic fragments such a linear B-epitopes, are provided.; In addition, variants of the bacterial lg-l ike domain (group 1 ) protein (orf405), yapH homolog (upec2820) and two different fragments of hemolysin A (recp3768) are provided herein that have increased solubility as compared to the native protein where the variants still raise a substantially similar immune response in a subject as the corresponding native protein.

Description

technical field [0001] The present invention relates to immunization against pathogenic Escherichia coli strains. Background technique [0002] E. coli strains are generally classified as commensal or pathogenic, and pathogenic strains are subdivided as enteric or extraenteric. Pathogenic E. coli are discussed in more detail in reference 1 and are grouped into different pathotypes, a group of E. coli strains that use a common set of virulence factors to cause a common disease. Pathotyping of strains is a routine technique and can be performed by genotyping or phenotyping. A recent genotyping-based pathogenic typing method [2] employs DNA microarrays. [0003] Among enteric strains, at least six well-described pathotypes are known: enteropathogenic (EPEC), enterohemorrhagic (EHEC), enteroaggregative (EAEC), enteroinvasive (EIEC), enterotoxigenic (ETEC) and diffusion adhesion (DAEC). [0004] Extraintestinal pathogenic strains of E. coli (or 'ExPEC' strains [3, 4]) include...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/245A61K39/02
CPCA61K39/00A61K39/0258C07K14/245A61P31/04A61P37/04Y02A50/30
Inventor L·塞里诺M·R·丰塔纳D·G·莫里尔
Owner NOVARTIS AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com